Treating Geographic Atrophy in Patients with Concurrent Neovascular AMD

Opinion
Video

A Retina expert discusses approaches for treating geographic atrophy in patients who also have neovascular AMD, presenting specific patient cases and providing key insights for successfully managing such cases.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content
PulseSight Therapeutics submits Clinical Trial Authorization for phase I trial of PST-611

PulseSight Therapeutics submits Clinical Trial Authorization for phase I trial of PST-611

Hattie Hayes
January 20th 2025
Article
Spotlighting telemedicine in the year of a pandemic

Spotlighting telemedicine in the year of a pandemic

Alex Delaney-Gesing
October 19th 2020
Podcast
Bausch + Lomb acquires Whitecap Biosciences

Bausch + Lomb acquires Whitecap Biosciences

Martin David Harp
January 13th 2025
Article
City Therapeutics and Bausch + Lomb collaborate on GA treatment candidate

City Therapeutics and Bausch + Lomb collaborate on GA treatment candidate

Sydney M Crago
January 13th 2025
Article
The FDA accepts revised supplemental New Drug Application for IZERVAY

The FDA accepts revised supplemental New Drug Application for IZERVAY

Sydney M Crago
January 10th 2025
Article
Aviceda Therapeutics completes $207.5 million Series C financing in support of AVD-104 for geographic atrophy treatment

Aviceda Therapeutics completes $207.5 million Series C financing in support of AVD-104 for geographic atrophy treatment

Martin David Harp
January 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.